Impact of Cantilever Design on Clinical, Radiographic, and Volumetric Parameters: a Retrospective Study

Sponsor
University of Catania (Other)
Overall Status
Completed
CT.gov ID
NCT06104163
Collaborator
(none)
40
1
80.2
0.5

Study Details

Study Description

Brief Summary

The present retrospective study aims to evaluate the impact of cantilever design in the posterior areas of the mandible on clinical, radiographic, and volumetric parameters with an 8-year follow-up.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Implant rehabilitation of posterior edentulous areas of the mandible is very complex because the presence of noble structures, such as the inferior alveolar nerve (NAI), often requires major reconstructive procedures to achieve adequate bone volume before implant placement.

    To overcome these potential problems and provide patients with sufficient function and esthetics, the use of single-unit crowns (SCs) supported by implants with cantilever extensions was introduced. The length and design of cantilever extensions are associated with possible detrimental effects on implant and prosthetic survival. In light of the above, the objective of the present study is to evaluate the impact of cantilever design in the posterior areas of the mandible on clinical, radiographic, and volumetric parameters with an 8-year follow-up.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    40 participants
    Observational Model:
    Other
    Time Perspective:
    Retrospective
    Official Title:
    Impact of Cantilever Design in the Posterior Areas of the Mandible on Clinical, Radiographic, and Volumetric Parameters: a Retrospective Study With 8-year Follow-up
    Actual Study Start Date :
    Mar 6, 2009
    Actual Primary Completion Date :
    Nov 8, 2015
    Actual Study Completion Date :
    Nov 10, 2015

    Outcome Measures

    Primary Outcome Measures

    1. Probing Depth of the Peri-implant Pocket (PPD) [8 years]

      It is measured from the mucosal margin to the bottom of the probable peri-implant sulcus and expressed in mm.

    2. Plaque Index (PI) [8 years]

      Evaluation of Plaque index (PI), expressed as the percentage of positive sites and measured at 4 implant sites (mesio-buccal, mesio-oral, disto-buccal and disto-oral) throught Michigan-grade periodontal probe.

    3. Keratinized mucosa (KM) [8 years]

      Evaluation of Keratinized mucosa width (KM), measured from the restoration margin to the mucogingival junction and expressed in mm.

    4. Mucosal recession (MR) [8 years]

      Mucosal recession (MR), of the peri-implant soft tissue, measured from the restoration margin to the mucosal margin and expressed in mm. Coronal from restoration margin is defined as (+) and apical from restoration margin defined as (-);

    5. Bleeding and/or suppuration on probing (BOP/SUP) [8 years]

      Evaluation of Bleeding and/or suppuration on probing (BOP/SUP), within 30 seconds after probing and expressed as the percentage of positive sites and measured at 4 implantation sites (mesio-buccal, mesio-oral, disto-buccal and disto-oral).

    Secondary Outcome Measures

    1. Volumetric analysis at baseline and after 8 years of follow-up [8 years]

      It was obtained by superimposing the intraoral scans of each patient, performed at baseline and eight years later through an optical scanner (3 Shape TRIOS 3 Germany GmbH), using 3D imaging software. The volumetric differences affecting the peri-implant soft tissues following prosthetic loading were expressed as a percentage and in mm3.

    2. Radiographic examination at baseline and after 8 years of follow-up [8 years]

      All patients enrolled in the study underwent periapical radiography performed with the long parallel cone technique at baseline and 8 years after. The measure linear peri-implant marginal bone levels (BML) of single unit crowns (SCs) is the perpendicular distance, expressed in mm, from the mesial and distal edge of the implant shoulder to the first bone-to-implant contact (BIC).

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Patients aged ≥18 years;

    • Patients with partial edentulism;

    • Patients with systemic health or controlled medical conditions;

    • Patients with healthy or treated periodontal conditions;

    • Patients enrolled in regular supportive periodontal therapy (SPT);

    • Patients without clinical signs of oral parafunctions (bruxism or clenching);

    • Presence of 1 osteointegrated dental implant in posterior region (premolar or molar) of mandible, after transmucosal placement and healing at 3-6 months;

    • Tissue level solid-screw implants with a sand-blasted and acid etched (SLA) surface with an endosseous diameter of 4.1 mm, a length of 8, 10 or 12 mm, a shoulder diameter of 4.8 mm and a supracrestal machined neck with a height of 1.8 mm (Straumann Dental Implant System, Institute Straumann AG); Use of prefabricated titanium abutments;

    • Monolithic zirconia SCs manufactured by digital flow; Screwed SCs with a mesial or distal cantilever extension;

    • Alternative crown design (ACD) with eccentric implant insertion, with crown-like-premolar and with distal or mesial cantilever with ovoid conformation. In the latter case, the lower abutment cross-section in the region between the crown-bridge connector mimics the shape of a root, creating an "interradicular" access route to facilitate oral hygiene maneuvers;

    • Absence of occlusal contacts or guidance on the cantilever extension at baseline;

    • Opposing dentition consisting of natural teeth or fixed or removable restorations;

    • Availability of periapical radiography at baseline (i.e., loading of SCs) and at the analyzed timings (after 1, 3, 5, and 8 years);

    • Availability of clinical measurements, such as pocket probing depth (PPD), plaque index (PI), bleeding index at probing (BOP), suppuration at probing (SUP), keratinized mucosa (KM), and mucosal recession (MR) taken at baseline (i.e., at loading of the SCs) and at 8 years after SCs loading, at four sites/implant with a Michigan graded periodontal probe (Deppeler SA); Availability of intraoral scans at baseline (i.e., at loading of the SCs) and at the analyzed time points (after 1, 3, 5, and 8 years after SCs loading) and executed using 3 Shape TRIOS 3, Germany GmbH.

    Exclusion Criteria:
    • Untreated or active periodontal diseases;

    • Type I implant placement;

    • SCs with cantilever extension replacing mandibular and maxillary incisors and canines;

      • SCs with cantilever extension replacing posterior maxillary;
    • SCs with cantilever extension supported by implants with a diameter ≤3.5 mm;

    • SCs supported by hollow-screw and hollow-cylinder implants;

    • Technical complications, such as fractures of implants, abutments, and the prosthetic artifact;

    • Smoking habit (more than 15 cigarettes/day);

    • Drug or alcohol abuse;

    • Uncontrolled systemic diseases that could affect bone remodeling during implant osseointegration; or soft tissue healing (e.g., uncontrolled diabetes mellitus with HbA1c>7, osteoporosis);

    • Use of medications that could affect bone remodeling during implant osseointegration or soft tissue healing (e.g., steroids, antiresorptive medication, radiotherapy);

    • Autoimmune and/or inflammatory diseases affecting the oral cavity;

    • Neurological or psychiatric handicap that could interfere with oral hygiene;

    • Pregnancy or lactation periods.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 AOU Policlinico G. Rodolico Catania Italy 95124

    Sponsors and Collaborators

    • University of Catania

    Investigators

    • Principal Investigator: Gaetano Isola, University of Catania

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Gaetano Isola, Researcher, University of Catania
    ClinicalTrials.gov Identifier:
    NCT06104163
    Other Study ID Numbers:
    • 121-28
    First Posted:
    Oct 27, 2023
    Last Update Posted:
    Oct 27, 2023
    Last Verified:
    Oct 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No

    Study Results

    No Results Posted as of Oct 27, 2023